Wednesday morning snapshot

A snapshot of the early morning's equity news and key market movements.

A bus passes the Bank of England
Source: Bloomberg

Last night in the US: The Dow Jones closed down 119 points at 16,818, the NASDAQ finished down 18 points at 4350 and the S&P 500 ended the day down 12 points at 1949.

This morning in London: The FTSE 100 is currently down 26 points at 6760.

FX and commodities: GBP/USD is down 30 pips at $1.6954, EUR/USD is up eight pips at $1.3614 and USD/JPY is down seven pips at ¥101.89. Brent crude is down 67 cents at $113.72 and gold  is trading at $1314, down $4.50.

Stocks: Land Securities has acquired a 30% stake in Kents shopping mecca Bluewater for £656 million. Because of unexpected cost cutting returns, Aberdeen Asset Management expects to be able to increase its dividend. While in the middle of a possible takeover battle, Shire has strengthened its hand with news that US regulators have approved its patent for its Vyvanse drug.  

The day ahead: UK monthly CBI retail sales figures are released this morning ahead of this afternoon's US Core dureable goods orders and final GDP figures.

All figures correct at 8.15am. All times London time.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.